Lindbrook Capital’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-254
| Closed | -$1.04K | – | 2923 |
|
2024
Q2 | $1.04K | Buy |
254
+135
| +113% | +$552 | ﹤0.01% | 2482 |
|
2024
Q1 | $1.88K | Buy |
+119
| New | +$1.88K | ﹤0.01% | 2265 |
|
2023
Q4 | – | Sell |
-416
| Closed | -$8.35K | – | 2849 |
|
2023
Q3 | $8.35K | Hold |
416
| – | – | ﹤0.01% | 1504 |
|
2023
Q2 | $11.7K | Hold |
416
| – | – | ﹤0.01% | 1369 |
|
2023
Q1 | $7.16K | Buy |
416
+408
| +5,100% | +$7.02K | ﹤0.01% | 1671 |
|
2022
Q4 | $161 | Sell |
8
-89
| -92% | -$1.79K | ﹤0.01% | 2765 |
|
2022
Q3 | $2K | Buy |
97
+12
| +14% | +$247 | ﹤0.01% | 2174 |
|
2022
Q2 | $2K | Buy |
+85
| New | +$2K | ﹤0.01% | 2085 |
|